Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06189638
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-12-06
Brief Title:
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Sponsor:
Jiangsu ProteLight Pharmaceutical Biotechnology Co Ltd
Organization:
Jiangsu ProteLight Pharmaceutical Biotechnology Co Ltd